Shinji Miura
Hokkaido University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shinji Miura.
Tetrahedron | 1997
Kenji Kitano; Shinji Miura; Hiroshi Ohrui; Hiroshi Meguro
Abstract 2-Deoxy- d -erythro-, ribo-, and arabino-pentofuranosylcytosines, which have a fluoromethyl group at the 4′-position, were synthesized. Introduction of fluorine was achieved by DAST treatment of 4-C- hydoxymethyl- d -ribofuranose , the key intermediate of 4′-C-methylnucleosides. Among these nucleosides, the 2′-deoxy derivative exhibited potent antineoplastic activity in vitro.
Japanese Journal of Cancer Research | 2001
Shinji Miura; Yuichi Yoshimura; Hiroshi Satoh; Shunji Izuta
The mechanism of action of the antitumor nucleoside analog l‐(2‐deoxy‐2‐fluoro‐4‐thio‐β‐D‐arabinofuranosyl)cytosine (4′‐thio‐FAC) was investigated. 4′‐Thio‐FAC inhibited cellular DNA synthesis, but not RNA and protein syntheses. We observed potent inhibitory action of the triphosphate of 4′‐thio‐FAC (4′‐thio‐FACTP) against DNA polymerase α, whereas it showed moderate inhibition of DNA polymerase P and little inhibition of DNA polymerase β. The kinetic analysis showed that the inhibition mode of 4′‐thio‐FACTP towards DNA polymerase a was mixed type, implying a chain‐terminating effect of 4′‐thio‐FACTP. The triphosphate of 2′‐deoxy‐2′,2′‐difluorocytidine (gemcitabine), a known antitumor nucleoside, did not show potent inhibition of these three DNA polymerases. Thus, the effect of the diphosphate of gemcitabine on ribonucleotide reductase was suggested to be more important for the antitumor action of gemcitabine. From these findings, the main target enzymes of 4′‐thio‐FAC and gemcitabine appear to be different. We found a synergistic effect of the two drugs in an in vitro model, which supports the above idea.
Nucleosides, Nucleotides & Nucleic Acids | 1997
Yuichi Yoshimura; Kenji Kitano; Mikari Watanabe; Hiroshi Satoh; Shinji Sakata; Shinji Miura; Noriyuki Ashida; Haruhiko Machida; Akira Matsuda
Abstract We have synthesized 4′-thioDMDC, 4′-thiogemcitabine, and 4′-thioarabinonucleosides, as potential antitumor and antiviral agents, originated from D-glucose. Biological activities of these compounds are also described.
Journal of Organic Chemistry | 1997
Yuichi Yoshimura; Kenji Kitano; Kohei Yamada; Hiroshi Satoh; Mikari Watanabe; Shinji Miura; Shinji Sakata; Takuma Sasaki; Akira Matsuda
Journal of Organic Chemistry | 1996
Yuichi Yoshimura; Kenji Kitano; Hiroshi Satoh; Mikari Watanabe; Shinji Miura; Shinji Sakata; Takuma Sasaki; Akira Matsuda
Current Drug Targets | 2004
Shinji Miura; Shunji Izuta
Cancer Letters | 1998
Shinji Miura; Yuichi Yoshimura; Mikari Endo; Haruhiko Machida; Akira Matsuda; Motohiro Tanaka; Takuma Sasaki
Bioorganic & Medicinal Chemistry Letters | 1998
Hiroshi Satoh; Yuichi Yoshimura; Shinji Sakata; Shinji Miura; Haruhiko Machida; Akira Matsuda
Bioorganic & Medicinal Chemistry | 2000
Yuichi Yoshimura; Kenji Kitano; Kohei Yamada; Shinji Sakata; Shinji Miura; Noriyuki Ashida; Haruhiko Machida
Archive | 1997
Kenji Kitano; Haruhiko Machida; Shinji Miura; Mikari Watanabe; Yuichi Yoshimura